Mitral valve replacement with bioprosthesis plus left atrial resection: A good alternative when Cox-maze procedure is not an option

Ovidio A García-Villarreal

2022, Number 3

<< Back Next >>

Cir Card Mex 2022; 7 (3)

Mitral valve replacement with bioprosthesis plus left atrial resection: A good alternative when Cox-maze procedure is not an option

García-Villarreal OA

Full text

How to cite this article

Language: English
References: 24
Page: 55-59
PDF size: 388.47 Kb.

ABSTRACT

We present herein one case of rheumatic calcified mitral valve disease and concomitant long-standing persistent atrial fibrillation. Since this patient was not a good candidate for mitral valve repair nor Cox-maze procedure, she was treated by means of a biological mitral valve replacement in conjunction with left atrial appendage resection. After three months, the patient continues in atrial fibrillation, with no oral anticoagulation regime. We present this case as an excellent alternative when Cox-maze procedure is not feasible for whatever reason. Left atrial appendage resection represents one step towards stroke prevention.

REFERENCES

Navia JJ. Acta Médica Colombiana 1998; 23(3): 96-99.
Iung B, Leenhardt A, Extramiana F. Management of atrial fibrillation in patientswith rheumatic mitral stenosis. Heart. 2018 Jul;104(13):1062-1068. doi: 10.1136/heartjnl-2017-311425.
Arora R, Kalra GS, Singh S, Mukhopadhyay S, Kumar A, Mohan JC, Nigam M.Percutaneous transvenous mitral commissurotomy: immediate and long-term follow-up results. Catheter Cardiovasc Interv. 2002 Apr;55(4):450-6. doi: 10.1002/ccd.10109.
Neumayer U, Schmidt HK, Fassbender D, Mannebach H, Bogunovic N, HorstkotteD. Early (three-month) results of percutaneous mitral valvotomy with theInoue balloon in 1,123 consecutive patients comparing various age groups. Am JCardiol. 2002 Jul 15;90(2):190-3. doi: 10.1016/s0002-9149(02)02452-9.
Garcia-Villarreal OA. Cox-Maze Procedure: Evolution and Clinical Implications.J Cardiol Curr Res 2017; 8(5): 00299. DOI: 10.15406/jccr.2017.08.00299.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for theManagement of Patients with Valvular Heart Disease: Executive SummaryA Report of the American College of Cardiology/American Heart AssociationJoint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932.
Vahanian A, Beyersdorf F, Praz F, et al; ESC/EACTS Scientific Document Group.2021 ESC/EACTS Guidelines for the management of valvular heart disease. EurHeart J. 2022;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation.Ann Thorac Surg. 2017 Jan;103(1):329-341. doi: 10.1016/j.athoracsur.2016.10.076.
Badhwar V, Rankin JS, Ad N, et al. Surgical Ablation of Atrial Fibrillation inthe United States: Trends and Propensity Matched Outcomes. Ann Thorac Surg.2017;104(2):493-500. doi: 10.1016/j.athoracsur.2017.05.016.
Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage:our most lethal human attachment! Surgical implications. Eur J CardiothoracSurg. 2000;17(6):718-22. doi: 10.1016/s1010-7940(00)00419-x.
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgicalpatients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755-9. doi:10.1016/0003-4975(95)00887-X.
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to preventstroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med.2007 Jun 19;146(12):857-67. doi: 10.7326/0003-4819-146-12-200706190-00007.
Whitlock RP, Belley-Cote EP, Paparella D, et al.; LAAOS III Investigators. LeftAtrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N Engl JMed. 2021 Jun 3;384(22):2081-2091. doi: 10.1056/NEJMoa2101897.
García-Villarreal OA, Heredia-Delgado JA. Orejuela izquierda en la enfermedadreumática mitral: principal fuente embolígena en la fibrilación auricular [Leftatrial appendage in rheumatic mitral valve disease: The main source of embolismin atrial fibrillation]. Arch Cardiol Mex. 2017;87(4):286-291. Spanish. doi:10.1016/j.acmx.2016.11.007.
Garcia-Villarreal OA. Superior septal approach for mitral valve surgery. InteractCardiovasc Thorac Surg. 2016;22(2):249-51. doi: 10.1093/icvts/ivv298.
Garcia-Villarreal OA. Superior septal approach to mitral valve surgery. Availableat: https://www.ctsnet.org/article/superior-septal-approach-mitral-valve-surgery.Last access: May 07, 2022.
Garcia-Villarreal OA. Hands-free approach for the left atrial appendage inCox maze IV. Asian Cardiovasc Thorac Ann. 2014 Nov;22(9):1141-3. doi:10.1177/0218492313518934.
García-Villarreal OA. Efectividad del procedimiento de Cox-maze III a largo plazoy su relación con el tamaño posoperatorio de la aurícula izquierda. Gac MedMex. 2019;155(6):590-595. doi: 10.24875/GMM.19005385.
Garcia-Villarreal OA. Not all patients are suitable for surgical ablation of atrialfibrillation: factors influencing failure. 2021. Oct. Presented at the 35th EACTSannual meeting.
Cox JL, Jaquiss RD, Schuessler RB, Boineau JP. Modification of the maze procedurefor atrial flutter and atrial fibrillation. II. Surgical technique of the maze IIIprocedure. J Thorac Cardiovasc Surg. 1995;110(2):485-95. doi: 10.1016/S0022-5223(95)70245-8.
Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patientswith atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118(5):833-40. doi:10.1016/s0022-5223(99)70052-8.
Ad N, Cox JL. Stroke prevention as an indication for the Maze procedure in thetreatment of atrial fibrillation. Semin Thorac Cardiovasc Surg. 2000;12(1):56-62.doi: 10.1016/s1043-0679(00)70018-9.
Garcia-Villarreal OA. Garcia-Villarreal OA. Surgical Closure of the Left AtrialAppendage. Basal Considerations before attempting with occluder devices. J SurgOpen Access 2017; 3(2): doi http://dx.doi. org/10.16966/2470-0991.144.
García-Villarreal OA. Left atrial appendage resection with cut-and-sew technique.Cir Card Mex 2019; 4(3): 96-99.